The short version of AEDG fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-27 and is reviewed periodically as new material appears.
The compound is described in the literature as a derivative of epithalamin, a preparation obtained from bovine pineal tissue. Work on this peptide family was carried out mainly by a research group in Saint Petersburg beginning in the 1980s, and the substance was later registered for clinical use in Russia under the name Epitalon. Outside that region it is generally treated as a research chemical rather than an approved medicine. Statements about its biological activity rest on a relatively small number of studies, and independent replication remains limited.
In its supplied form epitalon is a white to off-white powder, usually lyophilized and often hygroscopic. It dissolves readily in water and in aqueous buffers, and it is commonly handled as the acetate or trifluoroacetate salt to improve stability during purification and drying. The amide backbone is labile in aqueous media, so solutions are less durable than the dry solid. Handling notes in the chemical literature therefore emphasize keeping the powder dry, cool and shielded from light until it is dissolved.
Epitalon is a synthetic tetrapeptide whose sequence is alanine-glutamate-aspartate-glycine, written in single-letter code as AEDG. The four residues are joined by three peptide bonds, giving a linear backbone with no branching and no disulfide bridges. Its calculated molecular mass for the free form is approximately 390.3 daltons, a figure that rises when the compound is supplied as an acetate or trifluoroacetate salt. Because the chain is short, the molecule is defined entirely by its residue order rather than by any folded three-dimensional structure.
Verification of research-grade material involves comparing a supplier chromatogram against an in-house reference, checking the observed mass against the calculated value, and where possible confirming residue order by tandem mass spectrometry or enzymatic peptide mapping. Purity claims should be read alongside the method used to obtain them, because detection wavelength and integration settings alter the result. Batch-specific data, rather than a generic grade statement, is the informative part of a certificate.
Identity and purity of epitalon samples are normally established by reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, combined with mass spectrometry. The mass spectrum confirms the expected molecular ion and can reveal truncated or oxidised by-products. Amino acid analysis after acid hydrolysis verifies that the four residues are present in the expected ratio. Certificates typically report a purity figure taken from chromatographic peak area, expressed as a percentage of total integrated signal.
Lyophilised epitalon is generally held at minus twenty degrees Celsius in a sealed container kept dry and dark. Cooler conditions are sometimes recommended for long-term archives. The solid takes up moisture readily enough that repeated opening of a vial introduces water, so dividing a batch into smaller portions before storage lowers degradation risk. Aqueous solutions are less durable than the dry powder and are usually prepared shortly before use, then kept cold and shielded from light to slow hydrolysis and oxidation.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic tetrapeptide | Four residues, linear chain |
| Residue sequence | Ala-Glu-Asp-Gly | Single-letter form AEDG |
| Calculated mass | 390.3 daltons | Value for the free, uncharged form |
| Appearance | White to off-white powder | Usually supplied lyophilized |
| Solubility | Freely soluble in water | Often handled as a salt form |
The peptide emerged from research carried out in Saint Petersburg from the late 1980s onward, where investigators searched for shorter active fragments of a pineal preparation known as epithalamin. The name epitalon was chosen to reflect that parent extract. Early reports described effects on neuroendocrine markers and on the lifespan of laboratory animals. Much of that work appeared in Russian-language journals, with English translations following later, which affects how readily the original protocols can be assessed by outside groups.
Published studies on epitalon are dominated by a small number of research groups, and independent replication in other laboratories remains limited. Proposed mechanisms include activation of telomerase and modulation of melatonin rhythms, but the evidence for either rests mainly on cell cultures and animal models. Whether the peptide produces comparable effects in humans is an open question, and the absence of large controlled trials means the literature is best read as exploratory rather than settled.
Identity is normally established by reversed-phase high-performance liquid chromatography combined with mass spectrometry, a pairing that separates components and confirms molecular mass at once. Purity is quoted as a percentage from the chromatogram, and figures above ninety-five percent are a frequent commercial specification. Amino acid analysis or sequencing supplies further confirmation when required. Because many short peptides behave similarly under chromatography, retention time alone does not establish sequence; the mass measurement is what separates one tetrapeptide from another, and certificates should report both.
Short peptides such as AEDG are normally supplied as a freeze-dried solid and are kept dry, cold, and shielded from light. Holding at minus twenty degrees Celsius is common for the long term, while a refrigerator suffices for brief periods before use. The material takes up moisture to some degree, so containers should stay sealed and be allowed to reach room temperature before opening, which limits condensation on the contents. Repeated warming and cooling of a single container is discouraged because it admits water and can lower the amount of intact peptide.
The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.
Laboratory work has examined effects on telomerase activity in cultured cells, on melatonin rhythms in animals, and on markers of oxidative stress. Some experiments report measurable changes while others show none, and the reported findings rest largely on small studies. The absence of large independent trials means the generality of these results is unresolved rather than settled. Review articles occasionally apply the label geroprotector, a term that reflects a research hypothesis about ageing rather than an established clinical finding.
== History == Historical and archaeological evidence suggests that mastiffs have long been distinct in both form and function from the similarly large livestock guardian dogs from which they were most likely developed; they also form separate genetic populations. The Fédération Cynologique Internationale and some kennel clubs group the two types together as molossoid dogs; some modern livestock guardian breeds, such as the Pyrenean Mastiff, the Spanish Mastiff and the Tibetan Mastiff, and an extinct draught dog called the Belgian Mastiff, have the word "mastiff" in their name, but are not considered true mastiffs. Many older English sources refer to mastiffs as bandogs or bandogges, although technically the term "bandog" meant a dog that was tethered by a chain (or "bande") that would be released at night; the terms "mastiff" and "bandog" were often used interchangeably. In the twentieth century the term "bandog" was revived to describe some large fighting mastiff type dogs crossed with any bulldog in the United States.
=== Autoimmune diseases === Monoclonal antibodies used for autoimmune diseases include infliximab and adalimumab, which are effective in rheumatoid arthritis, Crohn's disease and ulcerative colitis by their ability to bind to and inhibit TNF-α. Basiliximab and daclizumab inhibit IL-2 on activated T cells and thereby help preventing acute rejection of kidney transplants. Omalizumab inhibits human immunoglobulin E (IgE) and is useful in moderate-to-severe allergic asthma.
==== Nitriles from glucosinolates in cruciferous plants ==== An important group of natural products that serve as precursors of nitriles are the mustard oil glycosides (glucosinolates), which are biosynthesized analogously to direct nitrile formation via an aldoxime intermediate. Glucosinolates constitute a major class of secondary metabolites produced by plants of the cruciferous family (Brassicaceae) for defense against herbivores and microorganisms. Normally, glucosinolates are hydrolyzed by myrosinase to isothiocyanates; however, in the presence of an additional protein (epithio specifier protein), nitriles are formed instead. Sinigrin is found primarily in horseradish, wasabi, and brown mustard, but also in head cabbage, kale, cauliflower, and Brussels sprouts; in addition to allyl isothiocyanate, it can be degraded to allyl cyanide (3-butenenitrile). Glucotropaeolin, present in garden cress, is degraded to phenylacetonitrile; gluconasturtiin, found in watercress, is degraded to 3-phenylpropionitrile. Sinalbin, occurring in Lepidium draba, can analogously be degraded to 4-hydroxyphenylacetonitrile.
The head is as large as an ordinary flour barrel, and has the shape of a sea lion head. The neck, if the creature may be said to have a neck, is of the same diameter as the body. The mouth is on the underside of the head and is protected by two tentacle tubes about eight inches in diameter and about 30 feet long. These tubes resemble an elephant's trunk and obviously were used to clutch in a sucker like fashion any object within their reach. Another tube or tentacle of the same dimensions stands out on the top of the head. Two others, one on each side, protrude from beyond the monster's neck, and extend fully 15 feet along the body and beyond the tail. The tail, which is separated and jagged with cutting points for several feet, is flanked with two more tentacles of the same dimensions as the others and 30 feet long. The eyes are under the back of the mouth instead of over it. This specimen is so badly cut up by sharks and sawfish that only the stumps of the tentacles remain, but pieces of them were found strewn for some distance on the beach, showing that the animal had a fierce battle with its foes before it was disabled and beached by the surf. Grant describes the animal as having seven "tentacles" and a "tail". If the "tail" is interpreted as another tentacle, giving a total of eight, this would suggest an octopus as opposed to a decapod, such as the squid or cuttlefish. Furthermore, nothing in the description indicates the presence of the long feeding tentacles found in squid, as the "tentacles" are said to be of the same dimensions.
== Prout's Hypothesis == Prout's hypothesis was an early 19th-century attempt to explain the properties of the chemical elements using the internal structure of the atom. In 1815, the English chemist William Prout observed that the atomic weights that had been measured were integer multiples of the atomic weight of hydrogen. Prout's hypothesis remained influential in chemistry throughout the 1820s. However, more careful measurements of the atomic weights, such as those compiled by Jöns Jakob Berzelius in 1828 or Edward Turner in 1832, appeared to disprove it. In particular the atomic weight of chlorine, which is 35.45 times that of hydrogen, could not at the time be explained in terms of Prout's hypothesis. It would take the better part of a century for this problem to be resolved.
Sources: en.wikipedia.org
=== Pluvicto and Xofigo for prostate cancer === Pluvicto also uses Lu-177 as the radioisotope (which is a beta emitter that decays to Hf-177) but its ligand is a prostate-specific membrane antigen (PSMA) targeted ligand as this radioligand therapy addresses metastatic prostate cancer. It was FDA approved in 2022. The difference between Lutathera and Pluvicto is shown in the chemical linkages in the images above. The production, transportation, and storage is the same as Lutathera. The therapy is administered intravenously through gravity, syringe, or a Peristaltic Infusion Pump. The major warnings include renal toxicity, infertility in males, and embryo/fetal harm. General side effects of this radioligand therapy include fatigue, nausea, dry mouth, anemia, decreased appetite, and constipation. Regular blood tests and imaging post-therapy are needed to see if the radioligand therapy is working and its side effects.
Beverly Gail Allitt (born 4 October 1968) is an English serial killer who was convicted of murdering three infants and an 11-year-old boy, attempting to murder three others, and causing grievous bodily harm to six more at Grantham and Kesteven Hospital, Lincolnshire, between February and April 1991. She committed the murders as a state enrolled nurse on the hospital's children's ward. Allitt administered large doses of insulin to at least two of her victims and a large air bubble was found in the body of another, but police were initially unable to establish how all of the attacks were carried out. In May 1993, Allitt received 13 life sentences at Nottingham Crown Court. The sentencing judge, Mr Justice David Latham, told Allitt that she was "a serious danger" to others and was unlikely ever to be considered safe enough to be released. Allitt is currently detained at Rampton Secure Hospital in Nottinghamshire. She became eligible for release on parole after her minimum tariff of 30 years' imprisonment expired in November 2021.
=== 2016–present: Move to Melbourne and suspension === Citing his friendship with incoming coach, Simon Goodwin, as the key reason for his move to Melbourne, Melksham noted the opportunity for a fresh start as another reason for his move. Melksham, along with 33 other Essendon players, were found guilty of using a banned performance-enhancing substance, thymosin beta-4, as part of Essendon's sports supplements program during the 2012 season. He and his teammates were initially found not guilty in March 2015 by the AFL Anti-Doping Tribunal, however, a guilty verdict was returned in January 2016 after an appeal by the World Anti-Doping Agency. He was suspended for two years which, with backdating, ended in November 2016; as a result, he served approximately fourteen months of his suspension and missed the entire 2016 season. After missing twelve months of football, Melbourne elected to ease Melksham back into training heading into the 2017 season, in which he did not join full training until January. With the intention to play the season on the half-back line and the wing, he played his first competitive match in Melbourne colours in the opening week JLT Community Series match against the Western Bulldogs at Whitten Oval playing as a defender. After playing all three matches in the JLT Community Series, he made his debut for Melbourne in the thirty point win against St Kilda at Etihad Stadium in round one.
== Side effects == Eflornithine is not genotoxic; no tumour-inducing effects have been observed in carcinogenicity studies, including one photocarcinogenicity study. No teratogenic effects have been detected.
Sources: en.wikipedia.org
== Polymorphs == Calcium carbonate crystallizes in three anhydrous polymorphs, of which calcite is the thermodynamically most stable at room temperature, aragonite is only slightly less so, and vaterite is the least stable.
== Role of internal medicine specialists == Internal medicine specialists, also referred to as general internal medicine specialists or general medicine physicians in Commonwealth countries, are specialized doctors trained to manage complex or multisystem disease conditions that single-organ specialists may not be equipped to handle. They are often called upon to address undifferentiated presentations that do not fit neatly within the scope of a single-organ specialty, such as shortness of breath, fatigue, weight loss, chest pain, confusion, or alterations in conscious state. They may manage serious acute illnesses that affect multiple organ systems concurrently within a single patient, as well as the management of multiple chronic diseases in a single patient. While many practitioners of internal medicine choose to subspecialize in specific organ systems, general internal medicine specialists do not necessarily possess any lesser expertise than single-organ specialists. Rather, they are specifically trained to care for patients with multiple simultaneous problems or complex comorbidities. Due to the complexity involved in explaining the treatment of diseases that are not localized to a single organ, there has been some confusion surrounding the meaning of internal medicine and the role of an "internist". Although internists may serve as providers of primary care, the term is not synonymous with "family doctor", "family practitioner" or "general practitioner" (GP).
== Approaches to Overcoming Size Limit == A major limiting factor in oligonucleotide synthesis is the progressive decline in yield as more nucleotides are included in the chain. Because each addition of a nucleotide is less than 100% efficient, the additive effect of coupling efficiency restricts a high yield synthesis to 13-200 nucleotides. The relationship between coupling efficiency and overall yield is described by the equation Y=CE^(n-1) where CE is the coupling efficiency, reported as a percentage, n representing the number of nucleotides, and n-1 representing the amount of coupling steps. As the number of coupling steps increases, the cumulative yield decreases exponentially. In response to yield constraints, various methodological improvements and alternative synthesis strategies have emerged to enhance coupling efficiency and extend oligonucleotide lengths:
When not flying, bats hang upside down from their feet, a posture known as roosting. Most megabats roost with the head tucked towards the belly, whereas most microbats roost with the neck curled towards the back. This difference is due to the structure of the cervical or neck vertebrae in the two groups, which are clearly distinct. Tendons allow bats to hang from a roost with no effort, which is needed to release. Bats are more awkward when crawling on the ground, though a few species, such as the New Zealand lesser short-tailed bat (Mystacina tuberculata) and the common vampire bat (Desmodus rotundus), are quite agile. These species move their limbs one after the other, but vampire bats accelerate by bounding, the folded-up wings being used to propel them forward. Vampire bats likely evolved these gaits to stalk their hosts, while short-tailed bats took to the ground due to a lack of competition from other mammals. Terrestrial locomotion does not appear to affect their ability to fly.
=== Sydenham's laudanum === In the 1660s English physician Thomas Sydenham (1624–1689) popularized a proprietary opium tincture that he also named laudanum, although it differed substantially from the laudanum of Paracelsus. In 1676 Sydenham published a seminal work, Medical Observations Concerning the History and Cure of Acute Diseases, in which he promoted his brand of opium tincture, and advocated its use for a range of medical conditions.
Sources: en.wikipedia.org
The peptide contains four residues in the order alanine, glutamate, aspartate and glycine, abbreviated AEDG. The chain is linear and held together by three peptide bonds. Its calculated mass for the uncharged free form is about 390.3 daltons.
Epithalamin refers to a crude preparation derived from bovine pineal tissue, which contains many components. Epitalon is a single synthetic tetrapeptide identified from that material and produced by chemical synthesis. The two names are sometimes confused because early reports treated the synthetic peptide as an active fragment of the extract.
It has been registered for clinical use in Russia, where it is associated with a small family of short peptides. In most other jurisdictions it is not an approved medicine and is traded as a research chemical. Regulatory status varies by country and changes over time.
The usual approach is reversed-phase HPLC with ultraviolet detection, reported as a percentage of total peak area. Mass spectrometry is used alongside chromatography to confirm identity rather than purity alone.